Follow the people · Insider

BA

Brian Adams

Insider · Chief Legal Officer · KYMR

Brian Adams files insider transactions with the SEC as a chief legal officer of Kymera Therapeutics (KYMR). We hold 1 disclosed purchase or sale filed since 17 April 2015, 1 of them in the last 90 days.

  • Files forKYMR
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure4 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 3 September 20254 September 2026Chief Legal Officer · Kymera Therapeutics (KYMR)9 Form 4 lines · source: SEC Form 4
  • Filed 20 July 202029 July 2025Chief Legal Officer · Relay Therapeutics (RLAY)63 Form 4 lines · source: SEC Form 4
  • Filed 15 April 201515 February 2018General Counsel and Secretary · Keryx Biopharmaceuticals (KERX)30 Form 4 lines · source: SEC Form 4

Everything they disclosed

102 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.